Clinical Trial: A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Randomized, Double Blind, Placebo Controlled, Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome
Brief Summary: To evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndrome.
Detailed Summary:
Sponsor: Kissei Pharmaceutical Co., Ltd.
Current Primary Outcome: Corneal staining score [ Time Frame: 6 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Conjunctival staining score [ Time Frame: 6 weeks ]
Original Secondary Outcome: Same as current
Information By: Kissei Pharmaceutical Co., Ltd.
Dates:
Date Received: September 1, 2011
Date Started:
Date Completion:
Last Updated: October 29, 2013
Last Verified: October 2013